Article
Recommendations for Clinical CYP2C19 Genotyping Allele Selection: A Report of the Association for Molecular Pathology.
The Journal of molecular diagnostics : JMD - 1 May 2018
Pratt Victoria M, Del Tredici Andria L, Hachad Houda, Ji Yuan, Kalman Lisa V, Scott Stuart A, Weck Karen E
Abstract excerpt
This document was developed by the Pharmacogenomics (PGx) Working Group of the Association for Molecular Pathology Clinical Practice Committee, whose aim is to recommend variants for inclusion in clinical pharmacogenomic testing panels. The goals of the Association for Molecular Pathology PGx Working Group are to define the key attributes of PGx alleles recommended for clinical testing and to define a minimum set...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
